Salvatore Santoli, International Nanobiological Testbed (INT)


  • Tell us about INT

    I started in nanotechnology as part of a group of international scientists. Having spent some time working in this exciting field, we thought there was scope to develop pioneering technology into commercial, practical solutions.  We formed INT in 1997 to develop nanotech ideas, enabling technologies.

    How far has INT come since you started the company?

    We have become an international company, mainly based in Italy, but we are developing all over the world, especially in the UK, with LBIC as our focal point. We have partnerships with organizations such as UCL and the London Technology Network. Now, we are looking for partnerships to expand further to form a consortia concentrating on the development of nanotechnology. 

    What does INT have to offer?

    We are mainly involved in research and development in Nanobiology, the sub category of Nanotechnology.  As in our name suggests ("testbed") we take lab results and ideas and turn them into commercial products on a mass scale. We are involved in securing funding for projects and I am currently working with the Technology Strategic Board for support.  We collaborate internationally.

    Where do you see INT in 5years?

    I believe that our care and patience in selecting technologies and projects will pay off. Real innovation will follow and I foresee rapid development, particularly in London.

    Why the UK/London?

    At the time we started the company; nanotechnology was very advanced in the UK and still is.  London is the place for investors and there are many agencies and funding opportunities. From a personal perspective, I enjoy London and am relieved to escape Italian politics!

    Where do you see Nanotechnology heading?

    Nanotechnology is such a massive sector; there are so many applications such as security and aerospace. Nanotech could be in everything, there are so many options to grow.  There is a big interest in materials at the moment, with nanotech making material stronger and more flexible with atomic accuracy; this is the USP for nanotech.

    You are a virtual client at LBIC, what the main advantages to you?

    LBIC is an important address to have on our business cards and gives us the opportunity to become a physical client in the future.  On my very first visit I saw the excellent laboratories, helpful team and great working environment.  LBIC provides a central base for us to work from in London, a world city and business capital.

    What is the most important attribute for a startup company in bioscience?

    I believe that business knowledge is as important as technical knowledge; you can't have one without the other.  I have economics and management experience which has been invaluable.  It is so important to do your homework before starting a company.

User log in

  • Email
  • Password